Benzinga | May 13, 2021 04:51PM EDT

Catabasis Pharmaceuticals Q1 EPS $(7.60) Down From $(0.50) YoY

Catabasis Pharmaceuticals (NASDAQ:CATB) reported quarterly losses of $(7.60) per share. This is a 1420 percent decrease over losses of $(0.50) per share from the same period last year.